(lp0
S'Stocks: The Brokerages Set Lexicon Pharmaceuticals, Inc.  Target Price ... Petro Global News 24 - Jan 7, 2017 A number of equities research analysts have recently issued reports on LXRX shares. Wedbush restated an outperform rating and issued a $33.00 price target on shares of Lexicon Pharmaceuticals in a research report on Tuesday, September 20th. Cowen&nbsp;...'
p1
aS'2 Key Events On The Horizon For Lexicon Pharmaceuticals Seeking Alpha - Jan 26, 2017 Lexicon Pharmaceuticals is a small biopharmaceutical company with clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications.'
p2
aS'The Long Case For Lexicon Pharmaceuticals Seeking Alpha - Feb 16, 2017 Lexicon Pharmaceuticals  is about to become a commercial stage company. The PDUFA date for telotristat ethyl  is on February 28, with a high likelihood of approval.'
p3
aS"Multiple Opportunities Ahead For Lexicon Pharmaceuticals Seeking Alpha - Dec 15, 2016 Lexicon Pharmaceuticals  has two late-stage clinical programs with major catalysts in the next few months. Although the company has had a long and rocky history, we would like to consider it from the perspective of 'here and now' taking a&nbsp;..."
p4
aS"Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 ... PR Newswire  - Mar 3, 2017 THE WOODLANDS, Texas, March 3, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. , today reported financial results for the three months and year ended December 31, 2016 and provided an overview of key milestones for the&nbsp;...Lexicon Pharmaceuticals'  CEO Lonnel Coats on Q4 2016 Results - Earnings ... - Seeking AlphaReview of Price Trends: Lexicon Pharmaceuticals, Inc.  - Is stories"
p5
aS'Estimating the intrinsic value of Lexicon Pharmaceuticals Inc  Simply Wall St - Mar 3, 2017 How far off is Lexicon Pharmaceuticals  to its intrinsic value? I am going to take a look now using a method called discounted cash flow or DCF.'
p6
aS'Lexicon Pharmaceuticals Announces Agreement To Buy Out Remaining Obligations ... PR Newswire  - Oct 5, 2016 THE WOODLANDS, Texas, Oct. 5, 2016 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc.  today announced that it has entered into an agreement to buy out its remaining obligations under its clinical development financing arrangement with&nbsp;...'
p7
aS'Lexicon To Present At The 16th Annual Needham Healthcare Conference PR Newswire  - Apr 3, 2017 THE WOODLANDS, Texas, April 3, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc.  announced today that Lexicon management will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017 at 8:40 a.m.'
p8
aS'Earnings Reaction History: Lexicon Pharmaceuticals Inc., 33.3% Follow-Through ... Nasdaq - Mar 3, 2017 Lexicon Pharmaceuticals Inc.  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p9
aS'Lexicon Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 27 Equities.com - Feb 27, 2017 Lexicon Pharmaceuticals Inc.  traded on unusually high volume on Feb. 27, as the stock gained 4.64% to close at $16.45.Lexicon Pharmaceuticals  Stock: FDA Approves XERMELO - CNA Finance '
p10
a.